July 18, 2026Blog6 min read
PX

Written by PX1 Research Team

PX1 chemists and research educators with hands-on experience in US-based peptide manufacturing, HPLC / mass-spectrometry lot testing, and endotoxin QC. All content is citation-backed and peer-reviewed for accuracy.

The Essential Guide to 5-Amino-1MQ Research in 2026

Research Guide
px1research.comResearch Use Only

Reviewed By

PX1 QC — Analytical Chemistry Team

Every article is reviewed by PX1's in-house analytical team for accuracy on mechanism, dosing ranges reported in the literature, and lab-handling guidance. We do not publish clinical or medical advice.


Quick answer

5-Amino-1MQ inhibits NNMT — a metabolic brake on the NAD+ salvage pathway. Mechanism, animal data, and purity considerations.

Reviewed by PX1 Research scientific team

Key takeaways

  • Reduced adipose tissue mass without reducing food intake
  • Improved insulin sensitivity
  • Increased NAD+ levels in adipose tissue
  • [NAD+ Research Guide](/research/nad-plus-research-guide)

What 5-Amino-1MQ is

5-Amino-1MQ (5-amino-1-methylquinolinium) is a small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT) — an enzyme that consumes cellular methyl donors (S-adenosyl methionine) and methylates nicotinamide, pulling it out of the NAD+ salvage pathway.

In simple terms: NNMT is a metabolic brake. Inhibiting NNMT unblocks NAD+ salvage and preserves methyl-donor availability.

Research findings

In animal models of diet-induced obesity, NNMT inhibition with 5-Amino-1MQ produced:

  • Reduced adipose tissue mass without reducing food intake
  • Improved insulin sensitivity
  • Preserved lean mass
  • Increased NAD+ levels in adipose tissue

The mechanism is metabolic, not appetite-driven — a distinction from GLP-1-class compounds.

Mechanism deep dive

NNMT expression is elevated in obese adipose tissue and correlates with metabolic dysfunction. By methylating nicotinamide to 1-methylnicotinamide (1-MNA), NNMT drains two resources at once: the NAD+ pool and cellular methylation capacity.

5-Amino-1MQ competitively inhibits NNMT, restoring both.

Structural notes

Technically 5-Amino-1MQ is a small molecule, not a peptide — but it's frequently grouped with metabolic research peptides because of its adjacent mechanism (NAD+ pathway) and its supply chain overlap with peptide research suppliers.

Laboratory handling

5-Amino-1MQ is typically supplied as a stable lyophilized powder. It is not sensitive to standard room-temperature handling. Reconstitution with bacteriostatic water is standard for research protocols.

Purity considerations

Because 5-Amino-1MQ is a small molecule, purity is verified by HPLC and NMR rather than mass spec + HPLC. Look for HPLC ≥98% and NMR identity confirmation on the COA.

  • NAD+ Research Guide
  • MOTS-c Research Guide

Research use only.

Frequently asked

All PX1 Research products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption.

Keep reading